Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

Bibliographic Details
Main Author: Coert J. Zuurbier
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cardiovascular Diabetology
Subjects:
SGLT2i
Hyperglycemia
Xylazine
Infarct size
Ischemia-reperfusion
Online Access:http://link.springer.com/article/10.1186/s12933-020-01119-z

Internet

http://link.springer.com/article/10.1186/s12933-020-01119-z

Similar Items